CMS Image-Guided Breast Biopsy Coverage Process To Be Reviewed By GAO
This article was originally published in The Gray Sheet
Executive SummaryThe General Accounting Office is investigating CMS' review of image-guided breast biopsy for palpable lesions as part of a study of coverage decisions for new procedures and devices
You may also be interested in...
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.